FDA Plans to Phase Out Animal Testing for Monoclonal Antibodies — What It Means for the Future of Drug Development
The United States Food and Drug Administration (FDA) recently announced a significant policy change. The FDA plans to phase out its requirement for animal testing in the safety evaluation of certain medicines, including monoclonal antibodies (mAbs). This change reflects the FDA’s effort to update drug testing practices with methods that are more relevant to human [...]